While the formulation patent for oral Wegovy remains valid in major markets such as the United States, the European Union, and Japan until 2039, the company explains that it can circumvent this through its proprietary formulation technology S-PASS. Ildong Pharmaceutical has also set a plan to achieve both technology licensing and entry into Phase 2 clinical trials this year for ID110521156, an oral GLP-1based new drug candidate
I cant just let it go because I felt sad or bad, you know
Your physician should assess for previously undiagnosed conditions affecting weight, review all current medications for potential interactions or weight-promoting effects, and verify appropriate dosing and injection technique
Rybelsus 14 mg Summary of Product Characteristics , electronic medicines compendium, 2026 [Accessed 29 June 2026]
Bacterial infection linked to endometriosis